Cancer immunotherapy: Primed for a response
- PMID: 25907340
- DOI: 10.1038/nrd4620
Cancer immunotherapy: Primed for a response
Comment on
-
Tetanus toxoid and CCL3 improve dendritic cell vaccines in mice and glioblastoma patients.Nature. 2015 Mar 19;519(7543):366-9. doi: 10.1038/nature14320. Epub 2015 Mar 11. Nature. 2015. PMID: 25762141 Free PMC article. Clinical Trial.
References
-
- Nature. 2015 Mar 19;519(7543):366-9 - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
